Entyvio: A Targeted Treatment for Ulcerative Colitis and Crohn’s Disease
Entyvio (vedolizumab) is a medication developed by Takeda Pharmaceuticals. The FDA first approved it on May 20, 2014 [1]. It is used to treat ulcerative colitis (UC) and Crohn’s disease. Entyvio is a type of medication called a monoclonal antibody...
